Effective and safe COVID-19 vaccines have been developed at a rapid and unprecedented
pace to control the spread of the virus, and prevent hospitalisations and deaths. However …

The GEHM series is an evidence-informed normative product of the WHO Health and
Migration Programme to inform policy-makers on migrationrelated public health priorities …

While the entire world prepares and begins to roll out COVID‐19 vaccines, the Philippines is
still reeling from the consequences of the Dengvaxia controversy in 2016. Those highly …

With the emergence of the highly transmissible Omicron variant, large-scale vaccination
coverage is crucial to the national and global pandemic response, especially in populous …

Member countries of the Association of Southeast Asian Nations (ASEAN) have faced
dengue outbreaks for decades, and the region has one of the highest rates of dengue …

This article applies a qualitative approach to the 2017 dengue vaccine controversy involving
Sanofi Pasteur's Dengvaxia to understand vaccine hesitancy and related anxieties in …

Background Several studies have highlighted that vaccine hesitancy (VH) is among the most
important threats to global health, especially in low-and middle-income countries, including …

Background Vaccine scares undermine longstanding global health achievements.
Remarkably little data has documented the lived experiences of policymakers working …

Global pandemics can be tackled by two means: lockdowns and vaccinations. As
vaccination has a low impact on economic outcomes and better acceptance by people, it is …

In the Philippines, dengue is probably the most wellknown and feared tropical disease. The
first recorded dengue epidemic in Southeast Asia occurred in Manila in 1954, and dengue …